Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at KELYA's multiple
$0.1396.8% below market
0.94 ZNTL revenue / share×0.14x KELYA P/S=$0.13
Market $3.99Implied $0.13
KELYA · current priceP/S 0.14x
$16.86Latest market snapshot
Implied fair value · at ZNTL's multiple
$513.662,946.6% above market
121.11 KELYA revenue / share×4.24x ZNTL P/S=$513.66
Market $16.86Implied $513.66